Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review

The emergence of data from clinical trials of biologics, the approval of new biologics, and our improved understanding of psoriasis pathogenesis have increased the therapeutic possibilities for the treatment of moderate-to-severe psoriasis. Biologics currently approved for the treatment of psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Thatiparthi, Akshitha, Martin, Amylee, Liu, Jeffrey, Egeberg, Alexander, Wu, Jashin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051287/
https://www.ncbi.nlm.nih.gov/pubmed/33861409
http://dx.doi.org/10.1007/s40257-021-00603-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051287/
https://www.ncbi.nlm.nih.gov/pubmed/33861409
http://dx.doi.org/10.1007/s40257-021-00603-w

Ejemplares similares